Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects

NCT01870674 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: YH12852
DRUG: Prucalopride
DRUG: Placebo

Sponsor

Yuhan Corporation